Long Term Follow up of Total Therapy IV: A Phase III Clinical Trial for Standard Risk Multiple Myeloma.
Al Hadidi S, Ababneh O, Schinke C, Thanendrarajan S, Bailey C, Smith RT, Panozzo S, Alapat D MD, Tricot GJ, Shaughnessy JD Jr, Zhan F, Sawyer JR, Siegel ER, Barlogie B, van Rhee F, Zangari M.
Al Hadidi S, et al. Among authors: zhan f.
Blood Adv. 2024 Dec 30:bloodadvances.2024014889. doi: 10.1182/bloodadvances.2024014889. Online ahead of print.
Blood Adv. 2024.
PMID: 39786380
No abstract available.